Article
Copy Number Alteration Signatures As Biomarkers in Cancer: A Review
23 Feb 2022
Abstract excerpt
Within certain cancers, extensive copy number alterations (CNAs) contribute to a complex and heterogenic genomic profile. This makes it difficult to understand and unravel the distinct molecular dynamics shaping the disease while preventing clinically effective patient stratification. CNA signature analysis represents a novel genomic stratification tool for probing this complexity, offering an intricate framework...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
